Primary |
Type 2 Diabetes Mellitus |
24.9% |
Diabetes Mellitus |
21.5% |
Product Used For Unknown Indication |
15.5% |
Drug Use For Unknown Indication |
11.2% |
Hypertension |
8.2% |
Arthralgia |
2.6% |
Osteoporosis |
2.6% |
Drug Use For Unknown Indication |
2.1% |
Ischaemic Heart Disease Prophylaxis |
1.7% |
Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
Renal Impairment |
1.7% |
Erectile Dysfunction |
1.3% |
Cardiac Failure Congestive |
0.9% |
Hypothyroidism |
0.9% |
Suicide Attempt |
0.9% |
Vitamin B12 Deficiency |
0.9% |
Arthritis |
0.4% |
Blood Cholesterol Increased |
0.4% |
Blood Glucose Abnormal |
0.4% |
Breast Cancer |
0.4% |
|
Renal Failure Acute |
16.4% |
Hypoglycaemia |
15.6% |
Overdose |
12.5% |
Suicide Attempt |
7.8% |
Drug Ineffective |
6.3% |
Toxicity To Various Agents |
5.5% |
Myocardial Infarction |
4.7% |
Completed Suicide |
3.1% |
Mental Status Changes |
3.1% |
Sudden Death |
3.1% |
Death |
2.3% |
Intentional Overdose |
2.3% |
Pancreatitis Acute |
2.3% |
Predisposition To Disease |
2.3% |
Somnolence |
2.3% |
Unresponsive To Stimuli |
2.3% |
Vomiting |
2.3% |
Weight Decreased |
2.3% |
Erythema |
1.6% |
Fracture |
1.6% |
|
Secondary |
Product Used For Unknown Indication |
29.3% |
Drug Use For Unknown Indication |
20.2% |
Type 2 Diabetes Mellitus |
11.2% |
Diabetes Mellitus |
10.5% |
Hypertension |
8.2% |
Helicobacter Infection |
4.9% |
Osteoporosis |
2.8% |
Bacteraemia |
1.9% |
Breast Cancer |
1.9% |
Duodenal Ulcer |
1.5% |
Renal Cancer |
1.1% |
Suicide Attempt |
1.0% |
Hyperlipidaemia |
0.9% |
Depression |
0.8% |
Drug Exposure During Pregnancy |
0.8% |
Prostate Cancer |
0.7% |
Renal Cell Carcinoma |
0.7% |
Prophylaxis |
0.6% |
Renal Impairment |
0.5% |
Antiinflammatory Therapy |
0.5% |
|
Wheezing |
12.2% |
Hypoglycaemia |
10.9% |
Sudden Death |
10.9% |
Renal Failure Acute |
9.0% |
Vomiting |
7.7% |
Completed Suicide |
5.8% |
Transaminases Increased |
5.8% |
Myocardial Infarction |
5.1% |
Toxic Epidermal Necrolysis |
5.1% |
Death |
3.8% |
Granulomatous Liver Disease |
3.8% |
Somnolence |
3.2% |
Hypoglycaemic Coma |
2.6% |
Weight Decreased |
2.6% |
Drug Interaction |
1.9% |
Glycosylated Haemoglobin Increased |
1.9% |
Poisoning |
1.9% |
Renal Failure |
1.9% |
Toxicity To Various Agents |
1.9% |
Transient Ischaemic Attack |
1.9% |
|
Concomitant |
Diabetes Mellitus |
20.8% |
Drug Use For Unknown Indication |
20.7% |
Hypertension |
18.0% |
Product Used For Unknown Indication |
7.3% |
Type 2 Diabetes Mellitus |
6.8% |
Rheumatoid Arthritis |
5.4% |
Dyslipidaemia |
3.0% |
Hiv Infection |
2.7% |
Colorectal Cancer |
2.0% |
Angina Pectoris |
1.4% |
Prophylaxis |
1.3% |
Colorectal Cancer Metastatic |
1.3% |
Constipation |
1.3% |
Diabetes Mellitus Non-insulin-dependent |
1.2% |
Nervousness |
1.2% |
Non-small Cell Lung Cancer |
1.2% |
Pain |
1.1% |
Prostate Cancer |
1.1% |
Thrombosis Prophylaxis |
1.1% |
Blood Pressure |
1.1% |
|
Vomiting |
19.1% |
Pneumonia |
7.7% |
Death |
7.0% |
Renal Failure Acute |
6.0% |
Myocardial Infarction |
5.4% |
Weight Decreased |
5.0% |
Pyrexia |
4.7% |
Urinary Tract Infection |
4.3% |
Hypertensive Emergency |
4.0% |
Dyspnoea |
3.7% |
Sepsis |
3.7% |
Syncope |
3.7% |
Lactic Acidosis |
3.3% |
Pain In Extremity |
3.3% |
Paraesthesia |
3.3% |
Renal Failure |
3.3% |
Somnolence |
3.3% |
Gastric Cancer |
3.0% |
Thrombocytopenia |
3.0% |
Urticaria |
3.0% |
|
Interacting |
Drug Use For Unknown Indication |
33.0% |
Hypertension |
10.8% |
Type 2 Diabetes Mellitus |
8.5% |
Diabetes Mellitus |
7.1% |
Helicobacter Infection |
7.1% |
Bronchitis |
3.8% |
Parkinson's Disease |
3.8% |
Ischaemic Heart Disease Prophylaxis |
3.3% |
Prophylaxis Against Gastrointestinal Ulcer |
3.3% |
Renal Impairment |
3.3% |
Gastric Ulcer |
2.4% |
Hyperlipidaemia |
2.4% |
Ill-defined Disorder |
2.4% |
Device Related Infection |
1.9% |
Insomnia |
1.9% |
Dysphagia |
1.4% |
C-reactive Protein Increased |
0.9% |
Dysthymic Disorder |
0.9% |
Gastritis |
0.9% |
Major Depression |
0.9% |
|
Hypoglycaemia |
44.4% |
Renal Failure Acute |
29.6% |
Hypomagnesaemia |
7.4% |
Galactorrhoea |
3.7% |
Hypoglycaemic Coma |
3.7% |
Nightmare |
3.7% |
Portal Vein Thrombosis |
3.7% |
Rash |
3.7% |
|